<DOC>
	<DOC>NCT00725413</DOC>
	<brief_summary>The primary purpose of this study is to investigate the contraceptive efficacy, safety and acceptability of Organon's subdermal etonogestrel implant in healthy female volunteers in various countries in order to obtain country-specific data.</brief_summary>
	<brief_title>A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (ImplanonÂ®)(P06473)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Eligible subjects are healthy premenopausal women requiring a longterm method of contraception, with a body mass index between 18 and 29 kg/m2, who are willing to give voluntary written informed consent. Subjects must have regular cycles with a usual length between 24 and 35 days. Male Postmenopause Infertile Under 18; Over 40</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>